{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Chen M"],"funding":["Key-Area Research and Development Program of Guangdong Province","National Key R&amp;D Program of China","National Key R&D Program of China","National Natural Science Foundation of China","Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program"],"pagination":["111-118"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7933295"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(1)"],"pubmed_abstract":["Myrcauones A-D (1-4), four new phloroglucinol-terpene adducts were isolated from the leaves of Myrciaria cauliflora. Their structures with absolute configurations were elucidated by combination of spectroscopic analysis, single crystal X-ray diffraction, and electronic circular dichroism (ECD) calculations. Compound 1 was a rearranged isobutylphloroglucinol-pinene adduct featuring an unusual 2,3,4,4a,10,11-hexahydro-1H-3,11a-methanodibenzo[b,f]oxepin backbone. Compound 4 showed moderate antibacterial activity against Gram-positive bacteria including multiresistant strains."],"journal":["Natural products and bioprospecting"],"pubmed_title":["Four New Phloroglucinol-Terpene Adducts from the Leaves of Myrciaria cauliflora."],"pmcid":["PMC7933295"],"funding_grant_id":["2017BT01Y036","81822042","2017YFC1703800","2020B1111110004","81630095"],"pubmed_authors":["Wang WJ","Ye WC","Chen M","Cao JQ","Li NP","Wu Y","Wang L"],"additional_accession":[]},"is_claimable":false,"name":"Four New Phloroglucinol-Terpene Adducts from the Leaves of Myrciaria cauliflora.","description":"Myrcauones A-D (1-4), four new phloroglucinol-terpene adducts were isolated from the leaves of Myrciaria cauliflora. Their structures with absolute configurations were elucidated by combination of spectroscopic analysis, single crystal X-ray diffraction, and electronic circular dichroism (ECD) calculations. Compound 1 was a rearranged isobutylphloroglucinol-pinene adduct featuring an unusual 2,3,4,4a,10,11-hexahydro-1H-3,11a-methanodibenzo[b,f]oxepin backbone. Compound 4 showed moderate antibacterial activity against Gram-positive bacteria including multiresistant strains.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Feb","modification":"2025-04-22T08:22:33.221Z","creation":"2025-04-05T22:30:35.35Z"},"accession":"S-EPMC7933295","cross_references":{"pubmed":["33280060"],"doi":["10.1007/s13659-020-00288-4"]}}